Last updated: 2026-09-06 07:41:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Celularity Inc. (CELU) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1,72, with a market capitalization of $53,84M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,56 to $2,55. This page covers its latest market performance, valuation, price trends and company information.
$53,84M | |
$1,83 | |
$134,00 | |
$0,56 | |
$1,83 | |
329,46K | |
-- | |
-- | |
$2,55 | |
$0,56 | |
-- | |
-- |
Celularity Inc. (CELU) last closed at $1,83 as of 2026-09-04 23:41:00, unchanged from the previous close of $1,83.
During the latest regular trading session, CELU traded between $0,56 and $134,00, with a volume of 329,46K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, Celularity Inc. (CELU) moved from $1,42 to $1,72, representing a gain of 21,13% ($0,30).
The stock traded between $1,65 and $1,84 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 34,65 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 58,3%
CELU is currently trading at $1,72, placing it 58,3% of the way from its 52-week low of $0,56 to its 52-week high of $2,55. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 115 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Celularity Inc. (CELU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.